Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Influenza
Related studies linked through entity extraction aliases.
Drug Use Investigation for Arepanrix® (H1N1)
- Status
- COMPLETED
- Phase
- N/A
Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults
- Status
- COMPLETED
- Phase
- PHASE4
Statin Therapy in Acute Influenza
- Status
- COMPLETED
- Phase
- PHASE2
A Study of VIS410 to Assess Safety and Pharmacokinetics
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Old
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Burden of Mild Outcomes (Physician Office Visits) Due to Influenza in the United States
- Status
- COMPLETED
- Phase
- N/A
Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention
- Status
- UNKNOWN
- Phase
- PHASE1
Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza Vaccine
- Status
- TERMINATED
- Phase
- PHASE1
Anti-Influenza Hyperimmune Intravenous Immunoglobulin Pilot Study (INSIGHT 005: Flu-IVIG Pilot)
- Status
- COMPLETED
- Phase
- PHASE1
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults
- Status
- COMPLETED
- Phase
- PHASE3
FluLaval® Quadrivalent Pregnancy Registry
- Status
- WITHDRAWN
- Phase
- N/A
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety of Two Influenza Vaccines in Children and Adolescents 3 to <18 Years of Age at Risk for Influenza-Related Complications
- Status
- COMPLETED
- Phase
- PHASE3
Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools
- Status
- COMPLETED
- Phase
- N/A
Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection
- Status
- WITHDRAWN
- Phase
- PHASE2
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE3